Epic Test Code LAB143 Beta-HCG: Quantitative
Performing Location(s)
BMC,CRH,LFH,OCH,FTT,FOX
Specimen Type
Serum or Plasma
Preferred Container
Gold or Red Top
Alternate Container
Green Top
Blood Tube Draw Volume
Min 50% draw volume
Minimum Volume to Submit for Testing
1.0 mL Serum/Plasma
- Multiple test can be performed from this volume. For question please contact the lab at 547-3975.
Storage Requirements
Sample tubes should be centrifuged within 2 hours of collection
Gold tops are stable in original tubes for 7 days DO NOT ALIQUOT
Aliquot Red tops after centrifuging
See Causes of Rejection for temperature requirements.
Transportation Needs
Deliver specimen to laboratory within 1 hour of collection if unspun. If not possible see "storage Requirements".
Reasons for Rejection
Mislabeled or Unlabeled Specimen
Less than 50% draw for Vacutainer tubes
> 2 days refrigerated
>8 hours room temperature
>48 hrs Frozen
Hemolysis > 500 mg/dL HgB
Lipemia > 3000 mg/dL Trig
Bilirubin > 40 mg/dL Bili
EDTA,Citrate, NaF, Oxalate
Limitations
Elevated hCG levels have also been associated with trophoblastic disease and nontrophoblastic neoplasms. The possibility of have these diseases should be considered before a diagnosis of pregnancy is made.
This test is not intended to be used for aiding in the diagnosis of cancer, or for monitoring the treatment of cancer patients.
This test is not for use as a tumor marker. For assay of Beta-HCG as a tumor marker see Reference Laboratory Test Beta-Human Chorionic Gonadotropin, Quantitative, Serum (LAB752).
Patient samples may contain heterophilic antibodies that could react in immunoassays to give falsely elevated or depressed results. A test that is inconsistent in the clinical symptoms and history should be interpreted with caution.
If clotting time is increased due to thrombolytic or anticoagulant therapy, the use of plasma specimens will allow for faster sample processing and reduce the risk of particulate matter.
Low BHCG values > 25 mIU/mL may be indicative of early pregnancy, but these results should always be evaluated in the context of the clinical situation (date of last menstrual period; pelvic examination). When borderline results are encountered, patient samples should be redrawn 48 hours later.
Reference Values
Population | Reference Range | Units |
Adult Males | 0-3 | mIU/mL |
Non-pregnant females, ages 18-40 | 0-6 | mIU/mL |
Non-pregnant females, ages >40 | 0-6 | mIU/mL |
Gestational Age | ||
0.2-1 week | 5-50 | mIU/mL |
1-2 weeks | 50-500 | mIU/mL |
2-3 weeks | 100-5,000 | mIU/mL |
3-4 weeks | 500-10,000 | mIU/mL |
4-5 weeks | 1,000-50,000 | mIU/mL |
5-6 weeks | 10,000-100,000 | mIU/mL |
6-8 weeks | 15,000-200,000 | mIU/mL |
2-3 months | 10,000-100,000 | mIU/mL |
Post-Menopausal females | 6-10 | mIU/mL |
This test should only be used in the assessment of pregnancy.
Days of Analysis
All
Synonyms
Quantitative Serum Pregnancy Test
Additional Information
This test should only be used for the assessment or pregnancy.
Methodology
Beckman AU/Dx/Access Series
CPT Code
84702
Last Updated
26-OCT-24 MS